spacer
spacer

PDBsum entry 5jw3

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Immune system PDB id
5jw3
Contents
Protein chains
316 a.a.
170 a.a.
222 a.a.
206 a.a.
Ligands
NAG-NAG-BMA-MAN
NAG-NAG
NAG

References listed in PDB file
Key reference
Title Structure and function analysis of an antibody recognizing all influenza a subtypes.
Authors N.L.Kallewaard, D.Corti, P.J.Collins, U.Neu, J.M.Mcauliffe, E.Benjamin, L.Wachter-Rosati, F.J.Palmer-Hill, A.Q.Yuan, P.A.Walker, M.K.Vorlaender, S.Bianchi, B.Guarino, A.De marco, F.Vanzetta, G.Agatic, M.Foglierini, D.Pinna, B.Fernandez-Rodriguez, A.Fruehwirth, C.Silacci, R.W.Ogrodowicz, S.R.Martin, F.Sallusto, J.A.Suzich, A.Lanzavecchia, Q.Zhu, S.J.Gamblin, J.J.Skehel.
Ref. Cell, 2016, 166, 596-608. [DOI no: 10.1016/j.cell.2016.05.073]
PubMed id 27453466
Abstract
Influenza virus remains a threat because of its ability to evade vaccine-induced immune responses due to antigenic drift. Here, we describe the isolation, evolution, and structure of a broad-spectrum human monoclonal antibody (mAb), MEDI8852, effectively reacting with all influenza A hemagglutinin (HA) subtypes. MEDI8852 uses the heavy-chain VH6-1 gene and has higher potency and breadth when compared to other anti-stem antibodies. MEDI8852 is effective in mice and ferrets with a therapeutic window superior to that of oseltamivir. Crystallographic analysis of Fab alone or in complex with H5 or H7 HA proteins reveals that MEDI8852 binds through a coordinated movement of CDRs to a highly conserved epitope encompassing a hydrophobic groove in the fusion domain and a large portion of the fusion peptide, distinguishing it from other structurally characterized cross-reactive antibodies. The unprecedented breadth and potency of neutralization by MEDI8852 support its development as immunotherapy for influenza virus-infected humans.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer